Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Poly(l-leucine)
2. Poly-l-leucine
3. Polyleucine
1. 328-39-2
2. H-dl-leu-oh
3. 2-amino-4-methylpentanoic Acid
4. Leucine, Dl-
5. (rs)-leucine
6. (+-)-leucine
7. Mfcd00063087
8. Leucine, Homopolymer
9. 2-amino-4-methyl-pentanoic Acid
10. Nsc46709
11. (+/-)-amino-4-methylpentanoic Acid
12. 1qss9d5dr6
13. Chebi:25017
14. 25322-63-8
15. Nsc-9252
16. ( Inverted Exclamation Marka)-leucine
17. Poly-l-leucine
18. 25988-64-1
19. Dl-2-amino-4-methylpentanoic Acid
20. 2-amino-4-methylpentanoicacid
21. Unii-1qss9d5dr6
22. Laevo-leucine
23. Leuzin
24. Hleu
25. Mfcd00002617
26. Mfcd00063088
27. Nsc-77687
28. D,l-leucine
29. 3h-leucine
30. D,1-leucine
31. Leucine #
32. .alpha.-amino-.gamma.-methylvaleric Acid
33. Nsc 9252
34. Einecs 206-328-2
35. L(+)-leucine
36. Norvaline, 4-methyl-
37. (.+-.)-leucine
38. Ai3-26709
39. L-leucine-[18o2]
40. (.+/-.)-leucine
41. Leu247
42. Leucine,(l)
43. Dl-leucine [fcc]
44. Schembl3888
45. .alpha.-aminoisocaproic Acid
46. Chembl46575
47. Wln: Qvyz1y1&1 -l
48. 2-amino-4-methyl Pentanoic Acid
49. Dtxsid00859050
50. Nsc9252
51. Wln: Qvyz1y1 & 1-d
52. Valeric Acid, 2-amino-4-methyl-
53. Dl-leucine, >=99% (hplc)
54. 73579-45-0
55. Hy-b1674
56. Nsc77687
57. (2r)-2-ammonio-4-methylpentanoate
58. Pentanoic Acid, 2-amino-4-methyl-
59. Ac7886
60. Dl-2-aminmo-4-methylvalerianic Acid
61. Lmfa01100048
62. Stl281857
63. Akos000118923
64. Akos016050505
65. Cs-w020700
66. Pb47827
67. 7005-03-0
68. Ac-24099
69. As-12287
70. Nci60_004103
71. Sy005863
72. Sy006365
73. Sy033229
74. Db-048277
75. Db-048278
76. Db-056575
77. Am20090485
78. Dl-leucine, Vetec(tm) Reagent Grade, 99%
79. Ft-0602784
80. Ft-0625480
81. Ft-0627930
82. Ft-0641848
83. Ft-0670765
84. Ft-0695062
85. Ft-0695813
86. Ft-0770717
87. Ft-0771371
88. L0028
89. (+/-)-2-amino-4-methylvaleric Acid
90. 328l392
91. A817787
92. A821451
93. Sr-01000944477
94. Q-100404
95. Sr-01000944477-1
96. Q60662890
97. F2191-0181
98. 8eb2668c-d303-4401-a7d5-8abd6b79b75f
| Molecular Weight | 131.17 g/mol |
|---|---|
| Molecular Formula | C6H13NO2 |
| XLogP3 | -1.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 131.094628657 g/mol |
| Monoisotopic Mass | 131.094628657 g/mol |
| Topological Polar Surface Area | 63.3 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 101 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 328-39-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 328-39-2, including repackagers and relabelers. The FDA regulates 328-39-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 328-39-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 328-39-2 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 328-39-2 supplier is an individual or a company that provides 328-39-2 active pharmaceutical ingredient (API) or 328-39-2 finished formulations upon request. The 328-39-2 suppliers may include 328-39-2 API manufacturers, exporters, distributors and traders.
click here to find a list of 328-39-2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
328-39-2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 328-39-2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 328-39-2 GMP manufacturer or 328-39-2 GMP API supplier for your needs.
A 328-39-2 CoA (Certificate of Analysis) is a formal document that attests to 328-39-2's compliance with 328-39-2 specifications and serves as a tool for batch-level quality control.
328-39-2 CoA mostly includes findings from lab analyses of a specific batch. For each 328-39-2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
328-39-2 may be tested according to a variety of international standards, such as European Pharmacopoeia (328-39-2 EP), 328-39-2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (328-39-2 USP).
LOOKING FOR A SUPPLIER?
